KUEMMERLE-DESCHNER, J. B. Et Al. 2011. Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes. ANNALS OF THE RHEUMATIC DISEASES , vol.70, no.12 , 2095-2102.

KUEMMERLE-DESCHNER, J. B., HACHULLA, E., CARTWRIGHT, R., Hawkins, P. N., TRAN, T. A., Bader-Meunier, B., ... HOYER, J.(2011). Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes. ANNALS OF THE RHEUMATIC DISEASES , vol.70, no.12, 2095-2102.

KUEMMERLE-DESCHNER, Jasmin Et Al. "Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes," ANNALS OF THE RHEUMATIC DISEASES , vol.70, no.12, 2095-2102, 2011

KUEMMERLE-DESCHNER, Jasmin B. Et Al. "Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes." ANNALS OF THE RHEUMATIC DISEASES , vol.70, no.12, pp.2095-2102, 2011

KUEMMERLE-DESCHNER, J. B. Et Al. (2011) . "Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes." ANNALS OF THE RHEUMATIC DISEASES , vol.70, no.12, pp.2095-2102.

@article{article, author={Jasmin B. KUEMMERLE-DESCHNER Et Al. }, title={Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2011, pages={2095-2102} }